Trastuzumab deruxtecan for HER2+ advanced breast cancer.
Future Oncol. 2022 Jan;18(1):7-19. doi: 10.2217/fon-2021-0550. Epub 2021 Nov 26.
Future Oncol. 2022.
PMID: 34823373
Review.